In unpremedicated patients presenting for general anaesthesia for electroconvulsive therapy (ECT), the use of atropine combined with methohexitone as an intravenous induction agent was found to produce a significantly greater increase in heart rate than glycopyrrolate in similar combination. There was no difference in the anti sialogogue effect of the two drugs at the doses used, and both drugs provided similar protection against the effects of suxamethonium and ECT on heart rate.
Introduction
The routine use of anticholinergics as premedicants is declining (Mirakhur et al. 1978a ). However,' there are still certain circumstances when anticholinergic premedication is essential. One such situation occurs in general dental practice whenever tracheal anaesthesia is employed. Atropine is commonly administered in such circumstances, often with the intravenous induction agent, and does provide effective drying. However, its use is frequently accompanied by an acceleration in heart rate which can be particularly disturbing in the patient with limited cardiac reserve or pre-existing dysrhythmias.
Glycopyrrolate is a recently-introduced anticholinergic agent. Studies in volunteers have shown that it has a potent antisialogogue effect, accompanied by minimal effects on heart rate (Mirakhur et al. 1978c) . A clinical study has confirmed that glycopyrrolate can produce effective drying without producing marked changes in heart rate (McCubbin et al. 1979) . However, there is no information on the effects of this drug when given concomitantly with an intravenous barbiturate -a procedure which is frequently employed in dental anaesthesia and anaesthesia for electroconvulsive therapy (ECT).
. The present study was therefore instigated to compare the changes in heart rate produced by the intravenous administration of atropine or glycopyrrolate with the induction agent in .patients about to undergo ECT.
Methods
Twenty-six physically healthy, ambulant patients, who were about to undergo ECT, took part in the study.
Induction of anaesthesia was accomplished with methohexitone sodium (Brietal) 1.3 mg/kg given intravenously with either atropine sulphate 0.6 mg or glycopyrrolate 0.2 mg which had been mixed with the methohexitone immediately before administration. The anticholinergic component was administered double-blind and allocation to either of these two drugs was on a random basis.
Pulse rate, from a 15-second measurement of the radial pulse, was recorded immediately before induction and at intervals of I, 2, 5, 10 and 60 minutes following injection of the 'induction mixture'. The dryness of the oropharynx was also assessed at these times by one of the investigators, using a three-point scale which consisted of I =dry, 2 =moist, 3 = unacceptably wet. Immediately after the one-minute assessment, suxamethonium 50 mg was given by intravenous injection, followed by oxygenation of the patient. The electric shock was given immediately after the two-minute assessment.
One hundred such observations were made from the patients participating in the study. The study protocol was approved by the Ethical Committee for Medical Research for Scarborough Health District. .
Due to the design of the trial, involving 100 observations from 26 patients, the responses are affected by the following forces: (I) between treatments; and (2) errors: (a) between subjects, and (b) within subjects between occasions. In a normal 'balanced' design, the effect of these errors can be readily determined. In the present study, because of an unbalanced design, the data were analysed by the Mixed Model Analysis of Variance using the BMDP03V computer program (Dixon et al. 1977) . 
Results
The physical characteristics of the patients are shown in Table 1 . Generally, the patients were well matched.
Oropharyngeal secretions were recorded as 'moist' in over 90~~of the observations, except at 60 minutes. There was no difference in the oropharyngeal secretions between the two groups. At 60 minutes following induction, a 'dry' oropharynx was recorded in 17% of the observations. Again, there was no difference between the groups in this respect.
The percentage change in heart rate from the values immediately before induction is shown in Figure 1 . The induction mixture containing atropine produced a greater increase in heart rate than that containing glycopyrrolate, although there did not appear to be any difference in the time taken to reach the maximum heart rate. Heart rate was significantly higher in the atropine group than in the glycopyrrolate group at one minute (P <. 0.025) and two minutes (P < 0.05). After that time, heart rate declined at a similar rate in both groups.
No significant changes in heart rate or rhythm were noted after the administration of either suxamethonium or the electric shock. 
Discussion
This study has shown that administration of 0.2 mg glycopyrrolate or 0.6 mg atropine with methohexitone provides adequate control of oropharyngeal secretions; a score of 'unacceptably wet' was not recorded at any of the assessment times. The use of atropine as an antisialogogue was, however, associated with a statistically significantly greater increase in heart rate than was glycopyrrolate.
Although there are no previously published data on the use of glycopyrrolate given simultaneously with an intravenous anaesthetic, the present data are broadly similar to those recorded by McCubbin et al. (1979) who administered atropine or glycopyrrolate approximately one hour before induction of anaesthesia. They showed that these doses of anticholinergic provided a similar degree of antisialogogue activity but that atropine produced a greater increase in heart rate. However, McCubbin et al. (1979) and Mirakhur and colleagues (1978b) showed that induction of anaesthesia with thiopentone was associated with a rise in heart rate. Similarly, Bernhoff et al. (1972) showed that methohexitone 2.4 mg/kg produced an increase in heart rate of approximately 35%. It is thus not possible in the present study to determine the contribution of the anticholinergic or the barbiturate to the development of the rise in heart rate. A recent study has shown that, when administered to anaesthetized subjects, the onset of action of glycopyrrolate is significantly slower than that of atropine (Mirakhur et al. 1981 ). In the present study there did not appear to be any significant difference in this respect, suggesting that the initial increase in heart rate was, at least in part, barbiturate-induced.
There was no obvious decrease in heart rate following the administration of suxamethonium which was given after the one-minute assessement. However, it is generally agreed that a marked fall in heart rate is usually observed only after repeated doses of this relaxant (Lupprian & Churchill-Davidson 1960) .
In conclusion, the present study has shown that the use of glycopyrrolate with methohexitone is associated with a smaller increase in heart rate whilst providing similar antisialogogue activity to atropine. Glycopyrrolate may thus be preferable to atropine when an intravenous anticholinergic agent is required in general anaesthesia.
